New insights into inflammatory bowel disease management from the latest American guidelines
Inflammatory bowel disease(IBD)is an idiopathic chronic inflammatory disease involving the gas-trointestinal tract,with many underlying causes.The etiology of IBD remains largely unknown.IBD has a tenden-cy of lifelong recurrence,lacking of optimal treatments and requiring multi-disciplinary diagnosis and care.With the rapid development of molecular basic research and clinical research related to IBD,new therapeutic drugs such as biologics and small molecule drugs are rapidly updated.In this review,the author summarizes the current sta-tus and progress of drug therapy for IBD based on guidelines or consensus from American Gastroenterological As-sociation recent years,in order to provide help for the standardized management of IBD in China.
inflammatory bowel diseaseulcerative colitisCrohn's diseasetreating to targetbiologicssmall molecule drugs
NETL
NSTL
万方数据
